Search research articles
Contact Us
Filters
Showing results (101-110 of 180) with videos related to
Page
of 18
Sort By:
Oncology Reports
|
July 30, 1999
Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells
N Normanno, G Tortora, A De Luca, et al.
Scientific Reports
|
December 31, 2024
Weighted gene co-expression network analysis reveals key stromal prognostic markers in pancreatic cancer
G Mantini, A Agostini, M Tufo, et al.
European Review for Medical and Pharmacological Sciences
|
March 4, 2024
Impact of muscle mass loss on outcomes in advanced or metastatic gastric cancer patients receiving a second-line treatment
V Zurlo, F Rosa, E Rinninella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2001
Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity
G Tortora, R Caputo, V Damiano, et al.
International Journal of Cancer
|
June 19, 2001
Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines
F Ciardiello, R Caputo, T Troiani, et al.
FEBS Letters
|
August 28, 1989
Site-selective 8-Cl-cAMP which causes growth inhibition and differentiation increases DNA (CRE)-binding activity in cancer cells
M I Mednieks, H Yokozaki, G R Merlo, et al.
Cancer Research
|
October 15, 1989
Inhibition of growth and modulation of gene expression in human lung carcinoma in athymic mice by site-selective 8-Cl-cyclic adenosine monophosphate
S Ally, T Clair, D Katsaros, et al.
Journal of the National Cancer Institute
|
July 22, 1998
Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide
F Ciardiello, R Caputo, R Bianco, et al.
Experimental Dermatology
|
June 26, 2023
Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis
A Chiricozzi, L Di Nardo, N Gori, et al.
Critical Reviews in Oncology/Hematology
|
January 4, 2026
The Microbiome in Head and Neck Squamous Cell Carcinoma: Biological Drivers, Therapeutic Interactions, and Emerging Clinical Applications
A Di Bello, A Scala, R Gili, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 180) with videos related to
Sort By:
Page
of 18
Oncology Reports
|
July 30, 1999
Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells
N Normanno, G Tortora, A De Luca, et al.
Scientific Reports
|
December 31, 2024
Weighted gene co-expression network analysis reveals key stromal prognostic markers in pancreatic cancer
G Mantini, A Agostini, M Tufo, et al.
European Review for Medical and Pharmacological Sciences
|
March 4, 2024
Impact of muscle mass loss on outcomes in advanced or metastatic gastric cancer patients receiving a second-line treatment
V Zurlo, F Rosa, E Rinninella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2001
Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity
G Tortora, R Caputo, V Damiano, et al.
International Journal of Cancer
|
June 19, 2001
Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines
F Ciardiello, R Caputo, T Troiani, et al.
FEBS Letters
|
August 28, 1989
Site-selective 8-Cl-cAMP which causes growth inhibition and differentiation increases DNA (CRE)-binding activity in cancer cells
M I Mednieks, H Yokozaki, G R Merlo, et al.
Cancer Research
|
October 15, 1989
Inhibition of growth and modulation of gene expression in human lung carcinoma in athymic mice by site-selective 8-Cl-cyclic adenosine monophosphate
S Ally, T Clair, D Katsaros, et al.
Journal of the National Cancer Institute
|
July 22, 1998
Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide
F Ciardiello, R Caputo, R Bianco, et al.
Experimental Dermatology
|
June 26, 2023
Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis
A Chiricozzi, L Di Nardo, N Gori, et al.
Critical Reviews in Oncology/Hematology
|
January 4, 2026
The Microbiome in Head and Neck Squamous Cell Carcinoma: Biological Drivers, Therapeutic Interactions, and Emerging Clinical Applications
A Di Bello, A Scala, R Gili, et al.
Page
of 18